Skip to main content
SpringerLink
Log in

14 Metabole leverziekten

  • Chapter
Leverziekten

  • 1743 Accesses

Samenvatting

In dit hoofdstuk worden enkele metabole leverziekten behandeld. Alfa-1-antitrypsinedeficiëntie is een erfelijke aandoening die geassocieerd is met long- en leverziekte. Cystic fibrosis is geassocieerd met leverziekte, waaronder cirrose en portale hypertensie. De ziekte van Wilson, eveneens een erfelijke aandoening, is een stoornis in het kopermetabolisme met gevolgen voor de lever.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatuur

  1. Fairbanks KD, Tavill AS. Liver disease in alpha-1-antitrypsin deficiency: a review. Am J Gastroenterol 2008; 103:2136–2141.

    Article  CAS  PubMed  Google Scholar 

  2. Teckman JH. Alpha-1-antitrypsin deficiency in childhood. Semin Liver Dis 2007;27:274–281.

    Article  CAS  PubMed  Google Scholar 

  3. Perlmutter DH, Brodsky JL, Balistreri WF, Trapnell BC. Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review. Hepatology 2007;45:1313–1323.

    Article  PubMed  Google Scholar 

  4. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver-cancer in alpha-1-antitrypsin deficiency. N Eng J Med 1986;314:736–739.

    Article  CAS  Google Scholar 

  5. Fischer HP, Ortiz-Pallardo ME, Ko Y, Esch C, Zhou H. Chronic liver disease in heterozygous alpha-1-antitrypsin deficiency PiZ. J Hepatol 2000;33:883–892.

    Article  CAS  PubMed  Google Scholar 

  6. Sveger T. Liver-disease in alpha-1-antitrypsin deficiency detected by screening of 200,000 infants. N Eng J Med 1976;294:1316–1321.

    Article  CAS  Google Scholar 

  7. Richtlijn Diagnostiek en Behandeling Cystic Fibrosis. Kwaliteitsinstituut voor de Gezondheidszorg CBO, 2007.

    Google Scholar 

  8. Wilschanski M, Durie PR. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 2007;56:1153–1163.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Cheng K, Ashby D, Smyth R. Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 1999;3: CD000222. DOI: 10.1002/14651858.

    Google Scholar 

  10. Brewer GK, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992;71:139–164.

    Article  CAS  PubMed  Google Scholar 

  11. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson’s disease. Lancet 2007;369:397–408.

    Article  CAS  PubMed  Google Scholar 

  12. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139–142.

    Article  PubMed  Google Scholar 

  13. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008;358:920–928.

    Article  CAS  PubMed  Google Scholar 

  14. Bhutani VK, Maisels MJ, Stark AR, Buonocore G. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or=35 weeks gestation. Neonatology 2008;94:63–67.

    Article  PubMed  Google Scholar 

  15. Colletti JE, Kothari S, Jackson DM, Kilgore KP, Barringer K. An emergency medicine approach to neonatal hyperbilirubinemia. Emerg Med Clin North Am 2007;25:1117–1135, vii.

    Google Scholar 

  16. Emerick KM, Whitington PF. Neonatal liver disease. Pediatr Ann 2006;35:280–286.

    Article  PubMed  Google Scholar 

  17. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006;117:474–485.

    Article  PubMed  Google Scholar 

  18. Suchy FJ. Neonatal cholestasis. Pediatr Rev 2004;25: 388–396.

    PubMed  Google Scholar 

  19. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, Deboer A, Oostra BA, Lindhout D, Tytgat GNJ, Jansen PLM, Oude Elferink RPJ, Chowdhury NR. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med 1995;333:1171–1175.

    Article  CAS  PubMed  Google Scholar 

  20. Robertson KJ, Clarke D, Sutherland L, Wooster R, Coughtrie MW, Burchell B. Investigation of the molecular basis of the genetic deficiency of UDP-glucuronosyltransferase in Crigler-Najjar syndrome. J Inherit Metab Dis 1991;14:563–579.

    Article  CAS  PubMed  Google Scholar 

  21. Thayyil S, Milligan DW. Single versus double volume exchange transfusion in jaundiced newborn infants. Cochrane Database Syst Rev 2006;CD004592.

    Google Scholar 

  22. Mil SW van, Houwen RH, Klomp LW. Genetics of familial intrahepatic cholestasis syndromes. J Med Genet 2005;42:449–463.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Oude Elferink RP, Paulusma CC, Groen AK. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology 2006; 130:908–925.

    Article  PubMed  Google Scholar 

  24. Kubitz R, Keitel V, Haussinger D. Inborn errors of biliary canalicular transport systems. Methods Enzymol 2005;400:558–569.

    Article  CAS  PubMed  Google Scholar 

  25. Wagner M, Trauner M. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis. Ann Hepatol 2005;4:77–99.

    CAS  PubMed  Google Scholar 

  26. Kelly DA, Davenport M. Current management of biliary atresia. Arch Dis Child 2007;92:1132–1135.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Senyuz OF, Yesildag E, Kuruoglu S, Yeker Y, Emir H. Caroli’s disease in children: is it commonly misdiagnosed? Acta Paediatr 2005;94:117–120.

    Article  CAS  PubMed  Google Scholar 

  28. Arroyo M, Crawford JM. Hepatitic inherited metabolic disorders. Semin Diagn Pathol 2006;23:182–189.

    Article  PubMed  Google Scholar 

  29. Pietrangelo A. Hereditary Hemochromatosis – A new look at an old disease. N Engl J Med 2004;350:2383–2397.

    Article  CAS  PubMed  Google Scholar 

  30. Beutler E. Iron storage disease: facts, fiction and progress. Blood Cells, Molecules & Diseases 39;2007:140–147.

    Article  CAS  Google Scholar 

  31. Powell LW, Dixon JL, Ramm GA, Purdie DM, Lincoln DJ, Anderson GJ, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006;166:294–301.

    Article  PubMed  Google Scholar 

  32. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008;358:221–230.

    Article  CAS  PubMed  Google Scholar 

  33. Pietrangelo A. Molecular insights into the pathogenesis of hereditary haemochromatosis. Gut 2006;55:564–568.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Swinkels DW, Janssen MCH, Bergmans J, Marx JJM. Hereditary hemochromatosis: Genetic complexity and new diagnostic approaches. Clinical Chemistry 2006; 52(6):950–968.

    Article  CAS  PubMed  Google Scholar 

  35. Bergmans JPH, Kemna EHJM, Janssen MCH, Jacobs EMG, Stalenhoef AFH, Marx JJM, Swinkels DW. Hereditaire hemochromatose: nieuwe genen, nieuwe ziekten en hepcidine. Ned Tijdschr Geneesk 2007;151: 1121–1127.

    CAS  Google Scholar 

  36. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107–1119.

    Article  CAS  PubMed  Google Scholar 

  37. > Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008;111(7):3373–6. (Epub 2007, Nov 19.)

    Google Scholar 

  38. Pietrangelo A. Non-invasive assessment of hepatic iron overload: are we finally there? J Hepatol 2005;42:153–154.

    Article  PubMed  Google Scholar 

  39. Pietrangelo A, Corradini E, Ferrara F, Vegetti A, De Jong G, Luca Abbati G, Paolo Arcuri P, Martinelli S, Cerofolini E. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. Blood Cells Mol Dis 2006;37:192–196.

    Article  CAS  PubMed  Google Scholar 

  40. Swinkels DW, Jorna ATM, Raymakers RAP. Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of Hereditary Hemochromatosis. Neth J Med 2007;65:452–455.

    CAS  PubMed  Google Scholar 

  41. Richtlijn Diagnostiek en behandeling hereditaire hemochromatose. Kwaliteitsinstituut voor de Gezondheidszorg CBO, 2008. (http://www.internisten.nl/home/richtlijnen/niv/niv/hemochromatose-niv/nvkc.)

  42. Jacobs EMG, Hendriks JCM, Marx JJM, Deursen CThBM van, Kreeftenberg HG, Vries RA de, Stalenhoef AFH, Verbeek ALM, Swinkels DW. First-degree relatives of C282Y homozygous probands with clinically detected hemochromatosis have increased morbidity compared to the general population. The HEmochromatosis FAmily Study (HEFAS). Neth J Med 2007; 2007;65:425–433.

    CAS  PubMed  Google Scholar 

  43. Poblete-Gutierrez P, Wiederholt T, Merk HF, Frank J. The porphyrias: clinical presentation, diagnosis and treatment. Eur J Dermatol 2006;16:230–240.

    CAS  PubMed  Google Scholar 

  44. Bonkovsky HL, Barnard GF. The porphyrias. Curr Treat Options Gastroenterol 2000;3:487–500.

    Article  PubMed  Google Scholar 

  45. Wijk HJ van, Baart de la FH, Berg JW Van Den, Edixhoven-Bosdijk A, Wilson JH. Blood exchange and transfusion therapy for acute cholestasis in protoporphyria. Dig Dis Sci 1988;33:1621–1625.

    Article  PubMed  Google Scholar 

  46. Bloomer JR. The porphyriasis. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff’s Diseases of the Liver. pp. 1231–60. 9th edn. Philadelphia: Lippincott Williams & Wilkins, 2003.

    Google Scholar 

  47. Chemmanur AT, Bonkovsky HL. Hepatic porphyrias: diagnosis and management. Clin Liver Dis 2004;8:807–38, viii.

    Article  PubMed  Google Scholar 

  48. Wilson JH, Rooy FW de, te VK. Acute intermittent porphyria in The Netherlands. Heterogeneity of the enzyme porphobilinogen deaminase. Neth J Med 1986; 29:393–399.

    CAS  PubMed  Google Scholar 

  49. Wiederholt T, Poblete-Gutierrez P, Gardlo K, Goerz G, Bolsen K, Merk HF, Frank J. Identification of mutations in the uroporphyrinogen III cosynthase gene in German patients with congenital erythropoietic porphyria. Physiol Res 2006;55(Suppl 2):S85–S92.

    CAS  PubMed  Google Scholar 

  50. Anstey AV, Hift RJ. Liver disease in erythropoietic protoporphyria: insights and implications for management. Postgrad Med J 2007;83:739–748.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Phillips JD, Whitby FG, Stadtmueller BM, Edwards CQ, Hill CP, Kushner JP. Two novel uroporphyrinogen decarboxylase (URO-D) mutations causing hepatoerythropoietic porphyria (HEP). Transl Res 2007;149: 85–91.

    Article  CAS  PubMed  Google Scholar 

  52. Meerman L. Erythropoietic protoporphyria. An overview with emphasis on the liver. Scand J Gastroenterol Suppl 2000:79–85.

    Google Scholar 

  53. Gross U, Hoffmann GF, Doss MO. Erythropoietic and hepatic porphyrias. J Inherit Metab Dis 2000;23:641–661.

    Article  CAS  PubMed  Google Scholar 

  54. Gisbert JP, Garcia-Buey L, Alonso A, Rubio S, Hernandez A, Pajares JM, Garcia-Diez A, Moreno-Otero R. Hepatocellular carcinoma risk in patients with porphyria cutanea tarda. Eur J Gastroenterol Hepatol 2004;16:689–692.

    Article  PubMed  Google Scholar 

  55. Siersema PD, Kate FJ ten, Mulder PG, Wilson JH. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver 1992;12:56–61.

    Article  CAS  PubMed  Google Scholar 

  56. Thunnissen PL, Meyer J, Koning RW de. Acute intermittent porphyria and primary liver-cell carcinoma. Neth J Med 1991;38:171–174.

    CAS  PubMed  Google Scholar 

  57. Cassiman D, Vannoote J, Roelandts R, Libbrecht L, Roskams T, Van Den OJ, Fevery J, Garmyn M, Nevens F. Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature. Acta Gastroenterol Belg 2008; 71:237–242.

    PubMed  Google Scholar 

  58. Beukeveld GJ, Wolthers BG. Laboratoriumdiagnostiek bij porfyrieën: stoornissen in de heemsynthese, pp. 3–14. 22e dr., 1997.

    Google Scholar 

  59. Beukeveld GJ, Bijleveld CM, Kuipers F, Kreeftenberg HG, Huizenga JR, Te VK, Wolthers BG. Evaluation and clinical application of the Enterotest for the determination of human biliary porphyrin composition. Eur J Clin Chem Clin Biochem 1995;33:453–462.

    CAS  PubMed  Google Scholar 

  60. Beukeveld GJ, Meerman L, Huizenga JR, Venekamp-Hoolsema EE, Gips CH, Wolthers BG. Determination of porphyrins in bile using high performance liquid chromatography and some clinical applications. Eur J Clin Chem Clin Biochem 1994;32:153–159.

    CAS  PubMed  Google Scholar 

  61. Parker M, Corrigall AV, Hift RJ, Meissner PN. Molecular characterization of erythropoietic protoporphyria in South Africa. Br J Dermatol 2008;159:182–191.

    Article  CAS  PubMed  Google Scholar 

  62. Bloomer J, Wang Y, Singhal A, Risheg H. Molecular studies of liver disease in erythropoietic protoporphyria. J Clin Gastroenterol 2005;39:S167–S175.

    Article  CAS  PubMed  Google Scholar 

  63. Lambrecht RW, Thapar M, Bonkovsky HL. Genetic aspects of porphyria cutanea tarda. Semin Liver Dis 2007;27:99–108.

    Article  CAS  PubMed  Google Scholar 

  64. Thunell S, Pomp E, Brun A. Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias. Br J Clin Pharmacol 2007;64:668–679.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  65. Kuo HC, Lee MJ, Chuang WL, Huang CC. Acute intermittent porphyria with peripheral neuropathy: a follow-up study after hematin treatment. J Neurol Sci 2007;260:231–235.

    Article  PubMed  Google Scholar 

  66. Sardh E, Rejkjaer L, Andersson DE, Harper P. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion. Clin Pharmacokinet 2007;46:335–349.

    Article  CAS  PubMed  Google Scholar 

  67. De Verneuil H, Robert-Richard E, Ged C, Mazurier F, Richard E, Moreau-Gaudry F. Successful gene therapy of mice with congenital erythropoietic porphyria . Med Sci (Paris) 2008;24:615–620.

    Article  Google Scholar 

  68. Seth AK, Badminton MN, Mirza D, Russell S, Elias E. Liver transplantation for porphyria: who, when, and how? Liver Transpl 2007;13:1219–1227.

    Article  PubMed  Google Scholar 

  69. Soonawalla ZF, Orug T, Badminton MN, Elder GH, Rhodes JM, Bramhall SR, Elias E. Liver transplantation as a cure for acute intermittent porphyria. Lancet 2004;363:705–706.

    Article  PubMed  Google Scholar 

  70. Stojeba N, Meyer C, Jeanpierre C, Perrot F, Hirth C, Pottecher T, Deybach JC. Recovery from a variegate porphyria by a liver transplantation. Liver Transpl 2004;10:935–938.

    Article  PubMed  Google Scholar 

  71. Do KD, Banner BF, Katz E, Szymanski IO, Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation 2002;73:469–472.

    Article  PubMed  Google Scholar 

  72. McGuire BM, Bloomer JR. Use of extracorporeal albumin dialysis for erythropoietic protoporphyria. Liver Transpl 2007;13:639–640.

    Article  PubMed  Google Scholar 

  73. Eefsen M, Rasmussen A, Wulf HC, Brock A, Hansen BA. Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices. Liver Transpl 2007;13:655–657.

    Article  PubMed  Google Scholar 

  74. Wahlin S, Aschan J, Bjornstedt M, Broome U, Harper P. Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis. J Hepatol 2007;46:174–179.

    Article  PubMed  Google Scholar 

  75. Rand EB, Bunin N, Cochran W, Ruchelli E, Olthoff KM, Bloomer JR. Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria. Pediatrics 2006;118:e1896–e1899.

    Article  PubMed  Google Scholar 

  76. McGuire BM, Bonkovsky HL, Carithers RL Jr., Chung RT, Goldstein LI, Lake JR, Lok AS, Potter CJ, Rand E, Voigt MD, Davis PR, Bloomer JR. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl 2005;11:1590–1596.

    Article  PubMed  Google Scholar 

  77. Rossmann-Ringdahl I, Olsson R. Porphyria cutanea tarda: effects and risk factors for hepatotoxicity from high-dose chloroquine treatment. Acta Derm Venereol 2007;87:401–405.

    Article  CAS  PubMed  Google Scholar 

  78. Sarkany RP. The management of porphyria cutanea tarda. Clin Exp Dermatol 2001;26:225–232.

    Article  CAS  PubMed  Google Scholar 

  79. Bertoli LF, Barton JC. Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer. Clin Breast Cancer 2007;7:716–718.

    Article  CAS  PubMed  Google Scholar 

  80. Roche M, Daly P, Crowley V, Darby C, Barnes L. A case of porphyria cutanea tarda resulting in digital amputation and improved by anastrazole. Clin Exp Dermatol 2007;32:327–328.

    Article  CAS  PubMed  Google Scholar 

  81. Rohrbach M, Clarke JT. Treatment of lysosomal storage disorders: progress with enzyme replacement therapy. Drugs 2007;67(18):2697–2716.

    Article  CAS  PubMed  Google Scholar 

  82. Torbenson M, Chen YY, Brunt E, Cummings OW, Gottfried M, Jakate S, Liu YC, Yeh MM, Ferrell L. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol 2006;30(4):508–513.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. afdeling Kindergastro-enterologie, UMCG, Groningen

    Prof.dr. H.J. Verkade

  2. afdeling Kindergastro-enterologie, UMCG, Groningen

    Dr. F.A.J.A. Bodewes

  3. afdeling Kindergastro-enterologie, UMC Utrecht, Utrecht

    Dr. R. Houwen

  4. afdeling Interne Geneeskunde, UMCG, Groningen

    Dr. R.A. de Vries

  5. afdeling Maag-, Darm- en Leverziekten, LUMC, Leiden

    Dr. B. van Hoek

  6. afdeling Metabole Ziekten (Divisie Kinderen), UMC Utrecht, Utrecht

    G. Visser

Authors
  1. Prof.dr. H.J. Verkade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. F.A.J.A. Bodewes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. R. Houwen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. R.A. de Vries
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dr. B. van Hoek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Visser
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. afdeling Maag-, Darm- en Leverziekten, Erasmus MC, Rotterdam

    H.L.A. Janssen

  2. afdeling Maag-, Darm- en Leverziekten, UMC St. Radboud, Nijmegen

    J.P.H. Drenth

  3. afdeling Maag-, Darm- en Leverziekten, LUMC, Leiden

    B. van Hoek

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Bohn Stafleu van Loghum, onderdeel van Springer Uitgeverij

About this chapter

Cite this chapter

Verkade, H., Bodewes, F., Houwen, R., de Vries, R., van Hoek, B., Visser, G. (2009). 14 Metabole leverziekten. In: Janssen, H., Drenth, J., van Hoek, B. (eds) Leverziekten. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-7437-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-7437-3_14

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-7436-6

  • Online ISBN: 978-90-313-7437-3

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation